Breast Cancer Cells Escape Immune Attack by Modifying MUC1
Author Information
Author(s): Kontani K, Taguchi O, Narita T, Izawa M, Hiraiwa N, Zenita K, Takeuchi T, Murai H, Miura S, Kannagi R
Primary Institution: Aichi Cancer Center
Hypothesis
Can breast cancer cells escape from autologous cytotoxic T-lymphocytes by modulating MUC1 mucin?
Conclusion
Breast cancer cells can evade immune attack by losing or altering the expression of MUC1, which limits the effectiveness of immunotherapy targeting this molecule.
Supporting Evidence
- Significant tumour cell lysis was observed in 8 out of 26 patients.
- 18 patients showed virtually no autologous tumour cell lysis.
- Patients with negligible tumour cell lysis had weaker expression of MUC1-related antigenic epitopes.
- A breast cancer cell line that did not express MUC1 was resistant to CTLs.
- Transfection of MUC1 cDNA into resistant cells induced significant lysis by T-lymphocytes.
Takeaway
Some breast cancer cells can hide from the body's immune system by changing a special protein called MUC1, making it harder for the immune system to fight the cancer.
Methodology
The study examined the killing of breast cancer cells by autologous lymphocytes in patients and analyzed MUC1 expression.
Participant Demographics
Patients with breast cancer, specifically 26 individuals.
Statistical Information
P-Value
p<0.0005–0.0045
Statistical Significance
p<0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website